On Monday, BTIG Research lowered its price objective for Privia Health Group (NASDAQ: PRVA), bringing it down from $45.00 to $40.00, as reported by The Fly. Before this, the price goal had been set at $45.00. Compared to where it is currently trading, the price target BTIG Research has established for the company represents an increase of 85.96%.
Over the past few days, several other research companies have provided their perspectives on PRVA. Canaccord Genuity Group rated the stock as a “buy” and decreased their target price for Privia Health Group from $50.00 to $43.00 in a research report published on Friday, November 11. The report was made available to the public. The report’s subject matter was the stock of the company. Piper Sandler stated their intention to set their price goal for Privia Health Group at $42.00 in a research note published on November 17. In a research note issued on Thursday, December 8, Stifel Nicolaus referred to the company Privia Health Group for the first time. They recommended “buying” the company’s stock and set a price target of $28.00. This recommendation was given to the company. The research note written by UBS Group on December 8 was the first time the company mentioned that it would be covering Privia Health Group. This was a Thursday. They recommended that the company “buy” the stock and establish a price objective of $30.00. The price objective that Truist Financial has set for Privia Health Group has been lowered to $41.00, according to an announcement made public in a research note published on Thursday, November 17. There have been twelve different analysts who have all concluded that investors should purchase the stock. According to Bloomberg, most analysts currently rate the stock as a ” buy, ” and its average price target is $39.46.
On Monday, the NASDAQ PRVA started accepting trades for $21.51, which was the opening price. Over the past 50 days, the stock price has reached a moving average of $24.62; over the past 200 days, that price has reached $31.84. The stock’s price-to-earnings ratio is -59.75, and its beta value is 0.67. The market value of the company’s shares is approximately 2.46 billion dollars. The lowest point for Privia Health Group over the past 52 weeks is $17.99, while the highest point for the company over the past 52 weeks is $44.64.
Privia Health Group (NASDAQ: PRVA), in a report made available to the public on November 10, provided details regarding the company’s performance. During that period, the company had a profit of $0.01 for each share it issued. The revenue the company brought in during the quarter was $342.90 million, which is higher than the forecasted amount of $323.66 million that it would bring in during the period. The return on equity for Privia Health Group was negative, coming in at 6.82%, and the net margin was also negative, coming in at 3.02%. These results indicate that the company is losing money. The current fiscal year of Privia Health Group is expected to end with a loss of 0.26 cents per share, as determined by the consensus of professionals in the relevant industry.
According to additional news concerning the company, on Tuesday, October 11, Privia Health Group director Jeffrey B. Butler sold 39,309 shares of the firm’s stock. This information was disclosed in another piece of news regarding the company. The price per share was determined to be $35.09 on average, which led to the total volume of stock sales amounting to 1,379,352.81 dollars worth of stock. Because of the transaction, the director now owns 3,039,637 shares of the company. The total value of these shares is $106,660,862.33, so the director’s holdings have increased significantly. Should you follow this link, you will be taken to the SEC filing in which the transaction was discussed in greater detail. On Thursday, October 13, Matthew Shawn Morris, Chief Executive Officer of the organization, completed the sale of 27,343 shares of the company’s stock. This news item is related to the previous one. The stock changed hands for a total of $954,270.70, which works out to a price of $34.90 per share throughout the transaction. The current Chief Executive Officer of the company is the owner of 121,739 shares in the company. The total value of these shares is $4,248,691.10. The sale of the company’s stock was made public through a filing with the SEC, which can be found on the SEC’s websiteutler sold 39,309 shares of the firm’s stock. This information was disclosed in another piece of news regarding the company. The price per share was determined to be $35.09 on average, which led to the total volume of stock sales amounting to 1,379,352.81 dollars worth of stock. Because of the transaction, the director now owns 3,039,637 shares of the company. The total value of these shares is $106,660,862.33, so the director’s holdings have increased significantly.
Should you follow this link, you will be taken to the SEC filing in which the transaction was discussed in greater detail. On Thursday, October 13, Matthew Shawn Morris, Chief Executive Officer of the organization, completed the sale of 27,343 shares of the company’s stock. This news item is related to the previous one. The stock changed hands for a total of $954,270.70, which works out to a price of $34.90 per share throughout the transaction. The current Chief Executive Officer of the company is the owner of 121,739 shares in the company. The total value of these shares is $4,248,691.10. The sale of the company’s stock was made public through a filing with the SEC, which can be found on the SEC’s website. This information was also reported in other news articles concerning the company. The price per share was determined to be $35.09 on average, which led to the total volume of stock sales amounting to 1,379,352.81 dollars worth of stock. Because of the transaction, the director now owns 3,039,637 shares of the company. The total value of these shares is $106,660,862.33, so the director’s holdings have increased significantly. Should you follow this link, you will be taken to the SEC filing in which the transaction was discussed in greater detail. On Thursday, October 13, Matthew Shawn Morris, Chief Executive Officer of the organization, completed the sale of 27,343 shares of the company’s stock. This news item is related to the previous one. The stock changed hands for a total of $954,270.70, which works out to a price of $34.90 per share throughout the transaction. The current Chief Executive Officer of the company is the owner of 121,739 shares in the company. The total value of these shares is $4,248,691.10.
The transaction was made public through a filing that was made with the SEC, which can be located on the website of the SEC. Jeffrey B. Butler, who serves as the company’s director, sold 39,309 shares of the company’s stock on Tuesday, October 11. The price of each share was calculated to be $35.09 on average after the sale of the shares, which brought in a total of $1,379,352.81 for the company. Following the completion of the transaction, the director will have a total of 3,039,637 shares in the company, which are currently valued at a sum equal to or greater than $106,660,862.33. Disclosures that are related to the sale might be found in this section of the website. Over the past ninety days, employees and other insiders of the company have sold 3,873,267 shares of company stock, bringing in a total of $91,138,284-57 from the transaction. Insiders currently own sixty percent of the total number of shares in the company.
Various institutional investors have recently adjusted their PRVA holdings, which can be seen below. Assetmark Inc. increased the amount of Privia Health Group stock owned by 119.4% during the second quarter of the year. Because the company purchased an additional 486 shares during the most recent quarter, Assetmark Inc. now has a total of 893 shares of its stock, which are currently valued at $26,000 and give the company a market capitalization of The total amount of Privia Health Group stock that First Horizon Advisors Inc. owned at the beginning of the second quarter was 4,330.4% higher than it was at the beginning of the quarter. First Horizon Advisors Inc. increased its holdings by 996 over the most recent quarter, bringing the total number of shares it currently owns to 1,019, with a value of $29,000. This growth brought the total number of shares it owns in the company to 1,019. During the third quarter, Signaturefd LLC spent approximately $32,000 to purchase additional shares of Privia Health Group to increase its existing stake in the company. In addition, Privia Health Group received a total investment contribution of $46,000 from Nisa Investment Advisors LLC during the second quarter. This investment was made during the quarter.
Last but not least, during the first quarter, Point72 Hong Kong Ltd. purchased an additional position in Privia Health Group that was valued at approximately $47,000. This was certainly not the least important transaction. Institutional investors currently own the company’s shares 66.83 percent.
It is common knowledge that Privia Health Group, Inc. is the leading provider of physician support services across the entirety of the United States. The company collaborates with medical organizations, insurance companies, and healthcare systems to enhance patient care, streamline physician workflows, and provide financial compensation to medical professionals who treat patients both in-person and remotely.
Source: news.google.com
